ACA vs DY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 20, 2026

ACA

57.5
AI Score
VS
ACA Wins

DY

44.8
AI Score

Investment Advisor Scores

ACA

58score
Recommendation
HOLD

DY

45score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ACA DY Winner
Forward P/E 29.8507 25.1256 DY
PEG Ratio 1.8642 3.5018 ACA
Revenue Growth 1.7% 45.6% DY
Earnings Growth 448.6% 14.4% ACA
Tradestie Score 57.5/100 44.8/100 ACA
Profit Margin 16.8% 4.8% ACA
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

ACA 1M: +1.8% · 3M: +2.9% DY 1M: -19.9% · 3M: -47.6%

Current Technical Phase

ACA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.5% over 20 days), RSI 82

RSI (14): 82.2 · Price: $149.15

DY

Markdown
Sell / avoid

Price below a falling SMA50 (slope -16.4%), weak momentum, RSI 21

RSI (14): 21.5 · Price: $225.16

Fundamentals Snapshot

Metric ACA DY
Market Cap — —
Forward P/E 29.1 16.5
Trailing P/E 36.4 21.7
Revenue (TTM) — —
Revenue Growth 0.0% 0.5%
Gross Margin 0.2% 0.2%
Operating Margin 0.1% 0.1%
EPS 4.09 10.95
Dividend Yield 0.00% —

Frequently Asked Questions

Based on our detailed analysis, ACA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.